• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Application o Market segments o Comparison by Application o Food and beverages and others - Market size and forecast 2019-2024 o Pharmaceuticals - Market size and forecast 2019-2024 o Clinical diagnosis - Market size and forecast 2019-2024 o Market opportunity by Application • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography o Market drivers o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o Agilent Technologies Inc. o bioMérieux SA o Bio-Rad Laboratories Inc. o Danaher Corp. o F. Hoffmann-La Roche Ltd. o Merck KGaA o PerkinElmer Inc. o Shimadzu Corp. o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2019 - 2024 ($ billion) • 13: Global market: Year-over-year growth 2019 - 2024 (%) • 14: Five forces analysis 2019 & 2024 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2019 • 21: Application - Market share 2019-2024 (%) • 22: Comparison by Application • 23: Food and beverages, and others - Market size and forecast 2019-2024 ($ billion) • 24: Food and beverages, and others - Year-over-year growth 2019-2024 (%) • 25: Pharmaceuticals - Market size and forecast 2019-2024 ($ billion) • 26: Pharmaceuticals - Year-over-year growth 2019-2024 (%) • 27: Clinical diagnosis - Market size and forecast 2019-2024 ($ billion) • 28: Clinical diagnosis - Year-over-year growth 2019-2024 (%) • 29: Market opportunity by Application • 30: Customer landscape • 31: Market share by geography 2019-2024 (%) • 32: Geographic comparison • 33: North America - Market size and forecast 2019-2024 ($ billion) • 34: North America - Year-over-year growth 2019-2024 (%) • 35: Europe - Market size and forecast 2019-2024 ($ billion) • 36: Europe - Year-over-year growth 2019-2024 (%) • 37: Asia - Market size and forecast 2019-2024 ($ billion) • 38: Asia - Year-over-year growth 2019-2024 (%) • 39: ROW - Market size and forecast 2019-2024 ($ billion) • 40: ROW - Year-over-year growth 2019-2024 (%) • 41: Key leading countries • 42: Market opportunity by geography ($ billion) • 43: Impact of drivers and challenges • 44: Vendor landscape • 45: Landscape disruption • 46: Industry risks • 47: Vendors covered • 48: Market positioning of vendors • 49: Abbott Laboratories - Overview • 50: Abbott Laboratories - Business segments • 51: Abbott Laboratories - Key offerings • 52: Abbott Laboratories - Key customers • 53: Abbott Laboratories - Segment focus • 54: Agilent Technologies Inc. - Overview • 55: Agilent Technologies Inc. - Business segments • 56: Agilent Technologies Inc. - Key offerings • 57: Agilent Technologies Inc. - Key customers • 58: Agilent Technologies Inc. - Segment focus • 59: bioMérieux SA - Overview • 60: bioMérieux SA - Business segments • 61: bioMérieux SA - Key offerings • 62: bioMérieux SA - Key customers • 63: bioMérieux SA - Segment focus • 64: Bio-Rad Laboratories Inc. - Overview • 65: Bio-Rad Laboratories Inc. - Business segments • 66: Bio-Rad Laboratories Inc. - Key offerings • 67: Bio-Rad Laboratories Inc. - Key customers • 68: Bio-Rad Laboratories Inc. - Segment focus • 69: Danaher Corp. - Overview • 70: Danaher Corp. - Business segments • 71: Danaher Corp. - Key offerings • 72: Danaher Corp. - Key customers • 73: Danaher Corp. - Segment focus • 74: F. Hoffmann-La Roche Ltd. - Overview • 75: F. Hoffmann-La Roche Ltd. - Business segments • 76: F. Hoffmann-La Roche Ltd. - Key offerings • 77: F. Hoffmann-La Roche Ltd. - Key customers • 78: F. Hoffmann-La Roche Ltd. - Segment focus • 79: Merck KGaA - Overview • 80: Merck KGaA - Business segments • 81: Merck KGaA - Key offerings • 82: Merck KGaA - Key customers • 83: Merck KGaA - Segment focus • 84: PerkinElmer Inc. - Overview • 85: PerkinElmer Inc. - Business segments • 86: PerkinElmer Inc. - Key offerings • 87: PerkinElmer Inc. - Key customers • 88: PerkinElmer Inc. - Segment focus • 89: Shimadzu Corp. - Overview • 90: Shimadzu Corp. - Business segments • 91: Shimadzu Corp. - Key offerings • 92: Shimadzu Corp. - Key customers • 93: Shimadzu Corp. - Segment focus • 94: Thermo Fisher Scientific Inc. - Overview • 95: Thermo Fisher Scientific Inc. - Business segments • 96: Thermo Fisher Scientific Inc. - Key offerings • 97: Thermo Fisher Scientific Inc. - Key customers • 98: Thermo Fisher Scientific Inc. - Segment focus • 99: Currency conversion rates for US$ • 100: Research Methodology • 101: Validation techniques employed for market sizing • 102: Information sources • 103: List of abbreviations • 104: Key Finding 1 • 105: Key Finding 2 • 106: Key Finding 3 • 107: Key Finding 5 • 108: Key Finding 6 • 109: Key Finding 7 • 110: Key Finding 8 • 111: Parent market • 112: Market characteristics • 113: Offerings of vendors included in the market definition • 114: Market segments • 115: Global - Market size and forecast 2019 - 2024 ($ billion) • 116: Global market: Year-over-year growth 2019 - 2024 (%) • 117: Five forces analysis 2019 & 2024 • 118: Bargaining power of buyers • 119: Bargaining power of suppliers • 120: Threat of new entrants • 121: Threat of substitutes • 122: Threat of rivalry • 123: Market condition - Five forces 2019 • 124: Application - Market share 2019-2024 (%) • 125: Comparison by Application • 126: Food and beverages and others - Market size and forecast 2019-2024 ($ billion) • 127: Food and beverages and others - Year-over-year growth 2019-2024 (%) • 128: Pharmaceuticals - Market size and forecast 2019-2024 ($ billion) • 129: Pharmaceuticals - Year-over-year growth 2019-2024 (%) • 130: Clinical diagnosis - Market size and forecast 2019-2024 ($ billion) • 131: Clinical diagnosis - Year-over-year growth 2019-2024 (%) • 132: Market opportunity by Application • 133: Customer landscape • 134: Market share by geography 2019-2024 (%) • 135: Geographic comparison • 136: North America - Market size and forecast 2019-2024 ($ billion) • 137: North America - Year-over-year growth 2019-2024 (%) • 138: Europe - Market size and forecast 2019-2024 ($ billion) • 139: Europe - Year-over-year growth 2019-2024 (%) • 140: Asia - Market size and forecast 2019-2024 ($ billion) • 141: Asia - Year-over-year growth 2019-2024 (%) • 142: ROW - Market size and forecast 2019-2024 ($ billion) • 143: ROW - Year-over-year growth 2019-2024 (%) • 144: Key leading countries • 145: Market opportunity by geography ($ billion) • 146: Impact of drivers and challenges • 147: Vendor landscape • 148: Landscape disruption • 149: Industry risks • 150: Vendors covered • 151: Market positioning of vendors • 152: Abbott Laboratories - Overview • 153: Abbott Laboratories - Business segments • 154: Abbott Laboratories - Key offerings • 155: Abbott Laboratories - Key customers • 156: Abbott Laboratories - Segment focus • 157: Agilent Technologies Inc. - Overview • 158: Agilent Technologies Inc. - Business segments • 159: Agilent Technologies Inc. - Key offerings • 160: Agilent Technologies Inc. - Key customers • 161: Agilent Technologies Inc. - Segment focus • 162: bioMérieux SA - Overview • 163: bioMérieux SA - Business segments • 164: bioMérieux SA - Key offerings • 165: bioMérieux SA - Key customers • 166: bioMérieux SA - Segment focus • 167: Bio-Rad Laboratories Inc. - Overview • 168: Bio-Rad Laboratories Inc. - Business segments • 169: Bio-Rad Laboratories Inc. - Key offerings • 170: Bio-Rad Laboratories Inc. - Key customers • 171: Bio-Rad Laboratories Inc. - Segment focus • 172: Danaher Corp. - Overview • 173: Danaher Corp. - Business segments • 174: Danaher Corp. - Key offerings • 175: Danaher Corp. - Key customers • 176: Danaher Corp. - Segment focus • 177: F. Hoffmann-La Roche Ltd. - Overview • 178: F. Hoffmann-La Roche Ltd. - Business segments • 179: F. Hoffmann-La Roche Ltd. - Key offerings • 180: F. Hoffmann-La Roche Ltd. - Key customers • 181: F. Hoffmann-La Roche Ltd. - Segment focus • 182: Merck KGaA - Overview • 183: Merck KGaA - Business segments • 184: Merck KGaA - Key offerings • 185: Merck KGaA - Key customers • 186: Merck KGaA - Segment focus • 187: PerkinElmer Inc. - Overview • 188: PerkinElmer Inc. - Business segments • 189: PerkinElmer Inc. - Key offerings • 190: PerkinElmer Inc. - Key customers • 191: PerkinElmer Inc. - Segment focus • 192: Shimadzu Corp. - Overview • 193: Shimadzu Corp. - Business segments • 194: Shimadzu Corp. - Key offerings • 195: Shimadzu Corp. - Key customers • 196: Shimadzu Corp. - Segment focus • 197: Thermo Fisher Scientific Inc. - Overview • 198: Thermo Fisher Scientific Inc. - Business segments • 199: Thermo Fisher Scientific Inc. - Key offerings • 200: Thermo Fisher Scientific Inc. - Key customers • 201: Thermo Fisher Scientific Inc. - Segment focus • 202: Currency conversion rates for US$ • 203: Research Methodology • 204: Validation techniques employed for market sizing • 205: Information sources • 206: List of abbreviations

Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., Shimadzu Corp., Thermo Fisher Scientific Inc.